Bill Commons

TN HB 2457

died on adjournment

TennCare - As introduced, requires a managed care organization or pharmacy benefits manager that is contracted with the bureau to reimburse a claim for a long-acting injectable drug intended for treatment and prevention of human immunodeficiency virus and administered in a pharmacy, physician's office, clinic, ambulatory surgical treatment center, or hospital. - Amends TCA Title 4; Title 56 and Title 71.

Tennessee · 114S1 · lower

Introduced
2026-02-04
Status date
—
Latest action
2026-03-03 — Taken off notice for cal in s/c Tenncare Subcommittee of Insurance Committee
Bill type
bill
Last updated
—

Subjects

Sponsors

  • Harrisprimary

Committees

Not provided by source.

Action timeline

  1. 2026-02-03

    Filed for introduction

    filing

  2. 2026-02-04

    Sponsor change.

    sponsorship

  3. 2026-02-04

    Intro., P1C.

    introduction

  4. 2026-02-05

    Assigned to s/c Tenncare Subcommittee

    referral-committee

  5. 2026-02-05

    P2C, ref. to Insurance Committee

    referral-committee

  6. 2026-02-25

    Placed on s/c cal Tenncare Subcommittee for 3/3/2026

  7. 2026-03-03

    Taken off notice for cal in s/c Tenncare Subcommittee of Insurance Committee

Versions

Documents

Votes

Not provided by source.

Related bills

Official source

https://wapp.capitol.tn.gov/apps/BillInfo/Default?BillNumber=HB2457&ga=114

Attribution

Data from openstates_bulk_csv, retrieved 2026-07-24T05:32:51.339172Z

Use this data

Every field on this page is available from the free public API — no key or licence required. Fetch this bill as JSON: GET /api/v1/bills?jurisdiction=TN&identifier=HB 2457. See the API docs or the MCP server for AI assistants.

Known limitations

  • Sponsor party and chamber affiliation are not yet captured by this API.
  • Committee referrals are not yet captured.
  • Some documents have no extracted text yet, so version comparison may be limited.

See the methodology page for data sources and limitations.